Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
An unusual pattern of recurrent cytokine release syndrome occurring during bispecific antibody therapy for multiple myeloma. Recognition of this phenomenon is essential to avoid misdiagnosis as infection.
MBS has evolved from a last-resort intervention to an effective, evidence-based therapeutic modality for obesity and its related medical conditions. The contraindications of the past are the indications of the future.
The use of aspirin in colorectal cancer should be targeted rather than routine. This algorithm integrates crucial factors such as absolute CRC risk, PI3K/PIK3CA status, and bleeding risk to maximize benefit while reducing harm.
Comparable long-term survival for patients undergoing robot-assisted or thoracoscopic esophagectomy for resectable esophageal squamous cell carcinoma, suggests the RAMIE trial.
The dose-dependent cardiotoxicities of anthracyclines require careful cardiovascular monitoring. Discover how the latest diagnostic advances in imaging modalities, biomarkers, and genetic screening are refining patient care.
CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.
This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only.
Genomic testing helps inform cancer diagnosis, prognosis, and treatment. A genomic report is generated by the laboratory carrying out next-generation sequencing to analyze biopsy samples. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.
An unusual pattern of recurrent cytokine release syndrome occurring during bispecific antibody therapy for multiple myeloma. Recognition of this phenomenon is essential to avoid misdiagnosis as infection.
Acquired von Willebrand syndrome represents a rare but significant complication of chronic lymphocytic leukemia. This patient achieved remission after treatment with venetoclax plus obinutuzumab.
Although colonic metastases from breast cancer are extremely rare, it is important for patients with a history of breast cancer who present with GI symptoms to undergo prompt endoscopic evaluation.
Recently there has been a renewed interest in the prospect of therapeutic cancer vaccines. But what exactly does it mean to vaccinate against cancer, where are vaccines showing the most promise, and what are the challenges of making such vaccines a reality?
Dr. Elias Sayour answers these questions and more in this episode.
Core-binding factor acute myeloid leukemia (CBF-AML) is traditionally classified as a favorable-risk subtype; however, outcomes in the Indian context have not mirrored this biological advantage. Relapse rates approaching 40% in both pediatric and …
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and joint destruction. Despite the availability of various treatment options, many patients remain refractory to conventional therapies. Recent advancements in …
Recent progress in nuclear medicine has been driven by continuous advances in radiotracers, imaging technologies, and radiopharmaceutical therapies, leading to an expansion of clinical applications supported by an increasing body of evidence. In …
Do you want to assess your biomarker testing skills and management decisions? Use these simulation-based case studies based on realistic NSCLC scenarios to do so in a practical and secure environment.
This educational activity was initiated, funded and co-developed by Boehringer Ingelheim and is intended for healthcare professionals in the UK and Ireland only.
Genomic testing helps inform cancer diagnosis, prognosis, and treatment. Access this educational microsite to learn more about typical genomic report content and how to interpret test results for patients with cancer.
Professor Joy Ho and a panel of Asia-Pacific-based experts will examine real-life patient cases in this Masterclass, exchanging insights into their clinical experiences of using CAR T-cell therapy to treat patients with R/R DLBCL or R/R FL.
This educational activity is not intended for healthcare professionals based in the UK, US, or off-label Asia-Pacific countries.
This hub presents a curated selection of educational materials focused on the latest clinically relevant topics related to the use of chimeric antigen receptor (CAR) T‑cell therapy for the treatment of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and R/R follicular lymphoma (FL).
This content has been developed in collaboration with and funded by the sponsor Novartis Pharma AG and is not intended for healthcare professionals based in the UK and US.
Liver cancer was the third leading cause of cancer-related mortality in 2022 and ranks among the most prevalent cancers worldwide [ 1 ]. Hepatocellular carcinoma (HCC) is the most common primary liver cancer, representing 75–85% of all cases …
Fontan surgery is a well-established palliative procedure for patients with complex congenital heart defects resulting in a single functional ventricle [ 1 ]. It is designed to separate the pulmonary and systemic circulations by connecting the …
An unusual pattern of recurrent cytokine release syndrome occurring during bispecific antibody therapy for multiple myeloma. Recognition of this phenomenon is essential to avoid misdiagnosis as infection.
MBS has evolved from a last-resort intervention to an effective, evidence-based therapeutic modality for obesity and its related medical conditions. The contraindications of the past are the indications of the future.